Point72 Hong Kong’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,800
Closed -$2.63M 572
2022
Q3
$2.63M Buy
5,800
+3,300
+132% +$1.58M 0.09% 276
2022
Q2
$1.21M Sell
2,500
-400
-14% -$198K 0.04% 476
2022
Q1
$1.43M Sell
2,900
-4,600
-61% -$2.1M 0.05% 412
2021
Q4
$3.48M Buy
7,500
+1,400
+23% +$589K 0.12% 183
2021
Q3
$2.27M Buy
6,100
+3,100
+103% +$1.18M 0.07% 399
2021
Q2
$1.15M Sell
3,000
-6,000
-67% -$2.29M 0.04% 660
2021
Q1
$3.23M Buy
9,000
+2,000
+29% +$643K 0.11% 241
2020
Q4
$2.25M Buy
+7,000
New +$2.15M 0.1% 246

Other funds holding ELV

Point72 Hong Kong's ELV Position: Q2 2025 in Review

Point72 Hong Kong sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 4,733 shares — an estimated $2.06M sold.

Point72 Hong Kong first reported a position in ELV in Q4 2014 and held it in 16 quarters. The position peaked at $18.9M in Q4 2023. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Point72 Hong Kong reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 4,733 Elevance Health shares in Q2 2025, an estimated $2.06M.
  • Point72 Hong Kong first reported a position in Elevance Health in Q4 2014 and held it in 16 quarters.
  • Point72 Hong Kong's Elevance Health position peaked at $18.9M in Q4 2023.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.